Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (301-310 of 557) with videos related to

Pageof 56
Sort By:
Nature Communications|August 26, 2020
Tissue sodium excess is not hypertonic and reflects extracellular volume expansionGiacomo Rossitto, Sheon Mary, Jun Yu Chen, et al.
European Heart Journal|March 21, 2023
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradoxJawad H Butt, Mark C Petrie, Pardeep S Jhund, et al.
European Journal of Heart Failure|November 27, 2025
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus documentLuca Monzo, Gianluigi Savarese, Wilfried Mullens, et al.
JACC. Cardiovascular Interventions|October 28, 2025
Revascularization in Ischemic Left Ventricular Dysfunction: A Pathophysiology-Guided, Evidence-Based ApproachMatthew Ryan, Alexander G Truesdell, Gavin J Murphy, et al.
Clinical Science (London, England : 1979)|December 16, 2024
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patientsStephen Rankin, Caitlin Fountain, Alastair J Gemmell, et al.
European Journal of Heart Failure|January 10, 2025
Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF)Joanna Osmanska, Kieran F Docherty, Colin Berry, et al.
Journal of the American College of Cardiology|September 1, 2024
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF ProgramSubodh Verma, Javed Butler, Barry A Borlaug, et al.
Plos One|August 4, 2021
Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancerRasmus Rørth, Marianne F Clausen, Emil L Fosbøl, et al.
European Journal of Heart Failure|February 16, 2012
Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failureColette E Jackson, Rachel C Myles, Ioannis K Tsorlalis, et al.
Circulation. Heart Failure|September 13, 2022
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population CohortPaul Welsh, Ross T Campbell, Leanne Mooney, et al.
Pageof 56

Showing results (301-310 of 557) with videos related to

Sort By:
Pageof 56
Nature Communications|August 26, 2020
Tissue sodium excess is not hypertonic and reflects extracellular volume expansionGiacomo Rossitto, Sheon Mary, Jun Yu Chen, et al.
European Heart Journal|March 21, 2023
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradoxJawad H Butt, Mark C Petrie, Pardeep S Jhund, et al.
European Journal of Heart Failure|November 27, 2025
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus documentLuca Monzo, Gianluigi Savarese, Wilfried Mullens, et al.
JACC. Cardiovascular Interventions|October 28, 2025
Revascularization in Ischemic Left Ventricular Dysfunction: A Pathophysiology-Guided, Evidence-Based ApproachMatthew Ryan, Alexander G Truesdell, Gavin J Murphy, et al.
Clinical Science (London, England : 1979)|December 16, 2024
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patientsStephen Rankin, Caitlin Fountain, Alastair J Gemmell, et al.
European Journal of Heart Failure|January 10, 2025
Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF)Joanna Osmanska, Kieran F Docherty, Colin Berry, et al.
Journal of the American College of Cardiology|September 1, 2024
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF ProgramSubodh Verma, Javed Butler, Barry A Borlaug, et al.
Plos One|August 4, 2021
Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancerRasmus Rørth, Marianne F Clausen, Emil L Fosbøl, et al.
European Journal of Heart Failure|February 16, 2012
Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failureColette E Jackson, Rachel C Myles, Ioannis K Tsorlalis, et al.
Circulation. Heart Failure|September 13, 2022
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population CohortPaul Welsh, Ross T Campbell, Leanne Mooney, et al.
Pageof 56